The Daily Toke

March 19, 2026

Ohio's massive overhaul of its cannabis laws takes effect Friday, March 20, after a pivotal referendum campaign fell short of its deadline. Ohioans for Cannabis Choice, the advocacy group leading the charge to block Senate Bill 56, failed to collect enough valid signatures by Thursday's cutoff—they needed more than 248,000 signatures from at least 44 of Ohio's 88 counties but ran out of time. The failed effort means Governor Mike DeWine's December-signed legislation will proceed unchallenged into law, marking a significant reversal from Ohio voters' 2023 decision to legalize recreational cannabis with 57 percent support. Dennis Willard, a spokesperson for the group, called the law government overreach and "a slap in the face" to those voters, warning it would shut down approximately 6,000 hemp and cannabis businesses and displace thousands of workers.

The new law introduces sweeping restrictions that reshape Ohio's cannabis market. 💰 MONEY MOVES THC potency limits drop dramatically—extracts will max out at 70 percent THC instead of 90 percent, and flower will be capped at 35 percent. The legislation bans the sale of unregulated intoxicating hemp products entirely, which eliminates a booming sector that emerged after legalization. It also prohibits THC-infused beverages at bars and breweries, criminalizes transporting marijuana across state lines into Ohio, and restricts public smoking in most spaces. Additionally, the law requires adult-use marijuana to remain in original packaging when not in use and mandates trunk transportation in vehicles. Advertising cannot claim any positive health or therapeutic effects—a blanket prohibition that contradicts years of peer-reviewed research on cannabis for chronic pain, anxiety, and PTSD symptoms.

The regulatory framework itself strengthens state control by reorganizing oversight under a restructured Division of Marijuana Control with expanded licensing, enforcement, and regulatory powers. One notable provision creates new expungement pathways for prior marijuana convictions, allowing courts to process requests for offenses that are now lower-level or no longer illegal. This partial measure offers some relief to individuals previously penalized under older prohibition frameworks, though it doesn't address the core concern: the state is effectively rolling back the very legalization voters approved just two years ago. 🤔 THINK ABOUT IT Ohio voters chose legal cannabis in 2023, but their elected representatives are now using the legislative process to gut that decision through restrictive regulations that didn't require voter approval—raising questions about whether voter-approved initiatives should be subject to legislative overrides.

The timing of Ohio's crackdown aligns with a broader national conversation about cannabis regulation. Last month, the New York Times Editorial Board published a striking reversal of its longtime position, backing more stringent marijuana regulation and warning against public health harms—a position that sparked nearly 4,000 reader comments and widespread social media debate. That national recalibration is bleeding into state politics, though the science behind Ohio's specific restrictions remains contested. The 35 percent flower limit and 70 percent extract cap appear designed to reduce potency-driven consumption, yet research on cannabis use patterns shows that consumers adjust frequency and quantity based on THC levels, and prohibition of higher-potency products often drives users toward unregulated markets or more harmful alternatives—a risk Senate Bill 56 explicitly creates by banning regulated hemp products.

What emerges from this sequence is a pattern worth examining: a state that legalized cannabis democratically is now using the legislative process to re-prohibit significant portions of the market. The hemp product ban particularly affects veterans and chronic pain patients who relied on unregulated but accessible THC drinks and edibles. The expungement provision offers symbolic justice for past convictions while the potency caps and advertising restrictions impose paternalistic market controls. 🤔 THINK ABOUT IT Alcohol kills approximately 95,000 Americans per year, and prescription opioids kill over 16,000 annually—yet neither faces potency caps, extraction restrictions, or advertising bans at the state legislative level. Cannabis, which has caused zero overdose deaths in recorded human history, is now subject to regulatory restrictions that seem disproportionate to documented harm. Whether that represents prudent public health policy or something else is a question Ohio voters will be watching closely.

March 19, 2026

# Hemp Ban Watch: A Nation Divided on Intoxicating Hemp as Federal Restrictions Loom

Across the country this week, states are charting wildly divergent courses on hemp-derived THC products—some tightening restrictions while others prepare to loosen them, all racing against a federal ban expected later in 2026. Ohio's new cannabis law took effect on March 20 after a referendum effort by Ohioans for Cannabis Choice failed to gather enough signatures to force a public vote. The group needed 248,000 valid signatures from at least 44 of Ohio's 88 counties by March 19 but ran out of time. The law, which takes effect immediately, bans the sale of unregulated intoxicating hemp products, caps THC in flower at 35%, reduces maximum THC in extracts from 90% to 70%, and criminalizes transporting marijuana across state lines into Ohio. Dennis Willard, spokesperson for the referendum group, called the law government overreach and "a slap in the face" to the 57% of Ohio voters who approved cannabis legalization in 2023. 💰 MONEY MOVES He warned the restrictions would shut down approximately 6,000 hemp businesses and put thousands of people out of work.

Meanwhile, Colorado is moving in the opposite direction. An upcoming bill backed by state Representatives Matthew Martinez and Steven Woodrow and Senator Julie Gonzales would dramatically expand access to hemp-derived THC beverages—currently restricted by a 15-to-1 CBD-to-THC ratio and a 1.75-milligram THC limit. The proposed measure would increase the THC limit to 10 milligrams in bars, restaurants, and dispensaries, and up to 3 milligrams in convenience stores and grocery stores. Brian Vicente, co-founder of the Colorado Hemp Beverage Coalition and architect of the 2012 Amendment 64 that legalized recreational marijuana, framed the move as preemptive protection for the state's hemp industry before federal restrictions take hold. "Once again, we're stepping forward and doing what's best for the state regardless of what happens federally," Vicente said. Around two dozen states already allow hemp-derived THC beverages in traditional retail settings, but Congress passed a federal ban on most hemp-derived THC products last November, making Colorado's move both strategically timed and legislatively bold.

In Nevada, Clark County took a middle path this week, implementing strict new regulations on hemp retail shops rather than banning products outright. Businesses must now obtain a "Hemp Retail Store" license, pay fees, and ensure employees have valid work cards. 🚀 THIS IS COOL All hemp products must remain in original, unopened packaging and be backed by lot-specific certificates of analysis from independent labs certified by the Nevada Cannabis Compliance Board. The county also requires third-party testing for potency, microbials, pesticides, and heavy metals, prohibits artificially derived cannabinoids and intoxicating products, and restricts sales to customers 21 and older. Clark County Director of Business Licensing Vincent Queano told commissioners that hemp products can pose health risks when contaminated, misdosed, or sold without consumer protections, noting that many lack rigorous third-party testing or uniform compliance standards. Commissioner Marilyn Kirkpatrick said she began pushing for regulation more than two years ago after noticing hemp stores appearing near the Strip and reviewing studies showing a rise in medical incidents among young and elderly consumers who unknowingly purchased intoxicating hemp products.

South Carolina's hemp industry is operating in limbo as seven different bills sit before the statehouse, with enforcement ramping up across the state but the law itself remaining murky. The situation reflects a broader national pattern: federal prohibition created a legal gray zone that states are now scrambling to fill—some with prohibition of their own, others with permissive frameworks, and still others with comprehensive regulation. 🤔 THINK ABOUT IT The federal government bans hemp-derived THC products citing consumer safety concerns, yet alcohol—which kills roughly 95,000 Americans annually—remains legal, taxed, and widely advertised. Cannabis has never caused a recorded overdose death in human history. So which regulatory approach actually serves public health: Ohio's business-shuttering restrictions, Colorado's retail-expansion framework, Clark County's rigorous testing mandate, or the federal ban itself?

The divergence reflects a deeper tension in American cannabis policy. States that legalized recreational marijuana in 2023 and later—like Ohio—are now scrambling to regulate a hemp market that exploded in the post-2018 Farm Bill era, creating a parallel economy of intoxicating products sold outside the licensed, tested, taxed cannabis supply chain. Other states like Colorado, already positioned as cannabis policy leaders, see an opportunity to integrate hemp beverages into the regulated market rather than push consumers toward unregulated alternatives. 💰 MONEY MOVES The stakes are economic and public health combined: the hemp retail sector represents thousands of small businesses, jobs, and tax revenue in some states, while unregulated products without consistent potency labeling or third-party testing create legitimate consumer safety concerns. The federal ban, likely to take effect in the coming months, will force even more states to choose between prohibition and state-level legalization—a familiar pattern that began with recreational marijuana and is now repeating with hemp. As of this week, the national trend remains unsettled: some states are doubling down on restriction, others are racing to protect their hemp markets through legalization, and the gap between federal law and state reality continues to widen.

March 19, 2026

# THC in Science: Major Mental Health Review Contradicts Patient Use, While New CBD Trial Shows Promise for Autism

A landmark systematic review published in The Lancet Psychiatry has dealt a significant blow to one of the most common reasons people seek medical cannabis prescriptions. The Australian research team, led by Dr. Jack Wilson at the University of Sydney's Matilda Centre, analyzed 54 randomized controlled trials conducted over the past 45 years and found no evidence that medicinal cannabis effectively treats anxiety, depression, or post-traumatic stress disorder—the three mental health conditions patients most frequently cite when pursuing cannabis-based treatments. The review, the largest of its kind, examined data from close to 2,500 patients and concluded that "in the absence of evidence at this time, the routine use of medical cannabis products really should be rarely justified for the treatment of mental health disorders." What makes this finding particularly striking is its timing: more than one million prescription approvals for cannabis have been issued in Australia over the past four years, with sales tripling as patients and doctors increasingly turn to cannabinoids for psychiatric relief despite this new evidence suggesting the approach lacks scientific foundation.

Yet the research landscape isn't uniformly bleak. 🚀 THIS IS COOL A separate trial published in Autism Research suggests that CBD oil may meaningfully reduce anxiety in autistic children and lower parenting stress—one of the few conditions where the mental health review found some supporting data, albeit deemed "low quality" by the authors. The study involved 29 children in a randomized, double-blind, placebo-controlled crossover trial lasting 32 weeks, with participants receiving 10 milligrams of CBD per kilogram of body weight daily. Researchers found that while the treatment didn't significantly alter broad social communication measures, it did ease specific anxiety-related challenges and noticeably reduced daily stress for parents managing children's behavioral difficulties. This distinction matters: while anxiety and depression showed no benefit from cannabis in the larger review, autism-specific anxiety appears to be a different neurological target, possibly because the endocannabinoid system may function differently in autistic brains. Nina-Francesca Parrella, a cognitive neuroscience researcher at Deakin University, emphasized that families are desperately seeking safe alternatives to conventional medications, which "are limited and can come with unpleasant side effects."

The mental health findings raise urgent questions about current prescribing practices, particularly given the documented risks. The Lancet review noted that while most side effects from cannabis were mild to moderate, serious concerns remain—including increased risk of psychotic symptoms, cannabis use disorder, and potential worsening of mental health outcomes. Dr. Wilson cautioned that routine use of medical cannabis "could be doing more harm than good by delaying the use of more effective treatments." The research did identify one legitimate therapeutic avenue: medicinal cannabis showed promise in helping people with cannabis use disorder reduce their consumption, presumably by lowering cravings through oral CBD-THC combinations. However, the same medicines increased cocaine cravings among people with cocaine use disorder, underscoring that cannabis is not a universal solution across substance-use conditions. 🤔 THINK ABOUT IT If the world's largest systematic review finds no evidence that cannabis treats the mental health conditions it's most commonly prescribed for, what does that say about the 700,000 Australians currently using it for anxiety, depression, and PTSD—and are they getting help, or just delay on evidence-based care?

The regulatory environment is shifting even as evidence gaps persist. 💰 MONEY MOVES Medicare is launching a CBD pilot program set to go live April 1, 2026, under the Center for Medicare and Medicaid Innovation, with CMS Administrator Mehmet Oz confirming that products can contain some THC—a significant policy move that effectively broadens access to cannabis-derived medicines through the federal insurance system for seniors and disabled Americans. This comes despite the mental health evidence vacuum, suggesting that policy is moving faster than science. The pilot's allowance for THC-containing products is notable because the Lancet review specifically highlighted that THC is psychoactive and linked to documented harms including paranoia in the short term and cannabis use disorder development long-term, whereas CBD is non-intoxicating and typically safe. The policy decision essentially lets Medicare patients access products containing the more problematic compound at a moment when large-scale evidence suggests those products don't treat the psychiatric conditions they're being prescribed for—a timing disconnect worth noting as normalization of cannabis proceeds independently of clinical validation in key therapeutic areas.

March 19, 2026

Texas hemp businesses are bracing for impact as new state regulations take effect March 31, reshaping one of the nation's largest cannabis markets through stricter THC measurement standards and dramatically increased licensing fees.

Under Executive Order GA-56, issued by Gov. Greg Abbott and adopted by the Texas Department of State Health Services, the state will now measure "total THC" — combining delta-9 THC and THCA, the naturally occurring compound in hemp that converts to delta-9 when smoked. Previously, products were legal if they contained less than 0.3% delta-9 THC alone. The change effectively bans virtually all smokable hemp products, including flower and extracts. 💰 MONEY MOVES The Texas hemp market generates between $10 billion and $12 billion annually and employs over 50,000 people. Mark Bordas, executive director of the Texas Hemp Business Council, warned of market disruption on a massive scale: "You're talking about shuttering stores — if these stay in place — that employ over 50,000 Texans." Hemp store operators project 60-70% revenue declines within three weeks, with some saying the rules will force closures outright. Allen Kirk, managing partner at Full Spectrum in San Angelo, noted that THCA products represent 35-50% of his store's sales. Licensing fees are also jumping from $155 to $5,000 for retail businesses and $10,000 for manufacturers — costs Kirk compared unfavorably to alcohol licensing, raising questions about the state's regulatory intent.

The economic stakes are compounded by concerns about consumer safety and unintended consequences. Veterans using smokable THCA products for PTSD and chronic pain rely on the faster onset compared to edibles or oils — a 15-minute difference that matters for managing acute symptoms. Kirk warned plainly: "Customers are going to go back to the street. They're going to buy sketchy products from sketchy individuals." Heather Fazio, director of the Texas Cannabis Policy Center, echoed this concern: "Effectively, this is going to ban hemp flower from the legal marketplace...Consumers enjoy the natural product with naturally occurring levels of THC in the hemp flower, and changing to these unreasonably restrictive testing standards would push this marketplace underground, handing it over to illicit operators because legitimate businesses can no longer sell it." 🤔 THINK ABOUT IT The state is banning a product with zero recorded overdose deaths while maintaining full legal access to alcohol, which kills approximately 95,000 Americans annually.

Law enforcement activity is also ramping up. Since August 2024, local and federal agencies have raided more than 15 hemp businesses across Texas, seizing products, cash, and assets that businesses have often not recovered. Many defendants have not been charged with crimes, yet the raids have generated headlines that some lawmakers have used to build public support for restrictions. Dallas attorney Chelsie Spencer, who helps hemp businesses stay compliant with complex regulations, described the impact: "They took everything from my client — his children's cellphones, every computer in the house, took all the vehicles, seized all assets, and froze all cash." The regulatory confusion is substantial. Spencer explained that businesses pay her firm "a phenomenal amount to stay compliant," vetting distributors and independently testing products — yet compliance provides no guarantee against enforcement action. As new rules take effect March 31, attorneys for hemp retailers fear raids will accelerate, using the new regulations as justification for enforcement that may make it nearly impossible for businesses to meet compliance thresholds.

The timing mirrors broader federal uncertainty. Congressional researchers recently updated their analysis of federal-marijuana policy, removing language suggesting the DEA will reschedule cannabis from Schedule I to Schedule III, instead saying the Department of Justice "may" take that action. Even if rescheduling occurs, Congressional Research Service analysts note it would not resolve the conflict between state-legal and federally prohibited products without additional legislation. Texas hemp businesses are essentially caught between state regulation designed to eliminate their industry and federal policy still in flux — left to navigate rules that change faster than they can comply with them.